Antennova, a clinical-stage biotech company focused on oncology today announced that it presented the latest data of CD73 ...
Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.
Alongside Summit, there are quite a few other players in the field. Some if these companies have even already shown promising ...
Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.
Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape ...
In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an ...
The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...
In a report released today, Robert Burns from H.C. Wainwright reiterated a Hold rating on Prelude Therapeutics (PRLD – Research Report), ...
Investor's Business Daily on MSN2d
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback